News | Structural Heart | July 13, 2020

Edwards Lifesciences and Abbott Settle Transcatheter Mitral Valve Device Patent Litigation

Abbott will receive a one-time payment and ongoing payments in connection to Edward's Pascal device sales

A comparison of the Edwards Pascal (left) and the Abbott MitraClip used for transcatheter mitral and tricuspid valve leaflet repairs. The two companies settled patent litigation regarding the devices today.

July 13, 2020 — Edwards Lifesciences Corp. and Abbott Vascular announced the two companies have reached an agreement to settle all outstanding patent disputes between the companies in cases related to transcatheter mitral and tricuspid repair products. 

The agreement will result in the dismissal of all pending cases or appeals in courts and patent offices worldwide, and includes a provision that the parties will not litigate patent disputes with each other in the field of transcatheter mitral and tricuspid repair and replacement products for the 10-year duration of the agreement. The injunctions currently in place against the sale of Edwards' transcatheter mitral and tricuspid repair system will be lifted.  

In connection with this agreement, Abbott will receive a one-time payment and ongoing payments based on the sales of the Edwards Pascal transcatheter valve repair system through 2025, as well as a potential sales milestone payment in 2026. The Pascal is very similar in design to the Abbott MitraClip device that is used for transcatheter mitral and tricuspid valve leaflet repairs.

Edwards said considers this agreement a positive development, as it allows the company to fully dedicate time and resources to helping patients.

Details of the settlement are confidential.

 

Related Transcatheter Mitral Valve Device Content:

Developments in Transcatheter Mitral Valve Replacement

Transcatheter Tricuspid Valve Repair Clip Device Cleared in Europe

New Study Looks at MitraClip use in Moderate Surgical Risk Patients

Edwards Pascal Tricuspid Valve Transcatheter Repair System Approved in Europe

Edwards Announces Research Milestones for Pascal Transcatheter Mitral Valve Program
 

 


Related Content

News | Cardiovascular Business

May 22, 2024 — Voiant (USA) and Thirona (The Netherlands) announced they have entered a global commercial partnership ...

Home May 22, 2024
Home
News | Cardiovascular Business

May 14, 2024 — GE HealthCare, a leading global medical technology, pharmaceutical diagnostics and digital solutions ...

Home May 14, 2024
Home
News | Cardiovascular Business

May 6, 2024 — SMT (Sahajanand Medical Technologies), a leading medical device company at the forefront of innovative ...

Home May 06, 2024
Home
Feature | Cardiovascular Business | By Melinda Taschetta-Millane

Clinical trials and innovative technology took center stage during the month of April, racking up some record number ...

Home May 03, 2024
Home
News | Cardiovascular Business

April 29, 2024 — Efforts by the American College of Cardiology, the American Heart Association, the Heart Failure ...

Home April 29, 2024
Home
News | Cardiovascular Business

April 9, 2024 — Cathie Biga, MSN, FACC, today became president of the American College of Cardiology and made history as ...

Home April 09, 2024
Home
News | Cardiovascular Business

April 5, 2024 — The Cardiovascular Research Foundation (CRF) has announced New York Valves: The Structural Heart Summit ...

Home April 05, 2024
Home
News | Cardiovascular Business

April 5, 2024 — Johnson & Johnson and Shockwave Medical, Inc. today announced that they have entered into a definitive ...

Home April 05, 2024
Home
Feature | Cardiovascular Business | By Melinda Taschetta-Millane

Here is a Top 10 look at the content that was trending during the month of March on dicardiology.com: 1. CLS Health ...

Home April 04, 2024
Home
News | Cardiovascular Business

March 19, 2024 — The American College of Cardiology (ACC) has selected 50 learners for its 2024 – 2025 Clinical Trials ...

Home March 19, 2024
Home
Subscribe Now